Hájek, R. Minarík, J. Straub, J. Pour, L. Jungova, A. Berdeja, J.G. Boccadoro, M. Brozova, L. Spencer, A. Van Rhee, F. Vela-Ojeda, J. Thompson, M.A. Abonour, R. Chari, A. Cook, G. Costello, C.L. Davies, F.E. Hungria, V.T.M. Lee, H.C. Leleu, X. Puig, N. Rifkin, R.M. Terpos, E. Usmani, S.Z. Weisel, K.C. Zonder, J.A. Barinová, M. Kuhn, M. Šilar, J. Cápková, L. Galvez, K. Lu, J. Elliott, J. Stull, D.M. Ren, K. Maisnar, V., Ixazomib-lenalidomide-dexamethasone in routine clinical practice: Effectiveness in relapsed/refractory multiple myeloma, Future Oncology, (17), 2499-2512, 2021, Future Medicine Ltd, 1479-6694, 1744-8301